... Gelatinases A and B Methods Enzymol 248 , 47 0 48 4 39 Nagase, H., Itoh, Y & Binner, S (19 94) Interaction of alpha 2-macroglobulin with matrix metalloproteinases and its use for identification of their ... Arrowheads show the 74/ 76 kDa doublet and 80 and 85 kDa forms of gelatinase in the CaCl2 treated material (B) The amount of TIMP-1 used was (lane 3), 10 (lane 4) and 20 nM (lane 5) In (A) and (B), at ... mechanisms of the precursors of matrix metalloproteinases 1, and Matrix Suppl 1, 237– 244 18 Liotta, L.A & Stetler-Stevenson, W.G (1991) Tumor invasion and metastasis: an imbalance of positive and negative...
... http://arthritis-research.com/content/9/5/221 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 B and L by cytokines in synovial fibroblast-like cells Br J Rheumatol 1997, 36:735- 743 Kaneko M, Tomita T, Nakase ... metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity Rheumatology (Oxford) 2006, 45 :41 4 -42 0 Vandooren ... transcription of cathepsin B [40 -42 ] The location of cathepsin B appeared to be restricted to synovial cells attached to cartilage and bone at sites of RA joint erosion [43 ] Accumulation of active...
... in 62 out of 82 patients with COPD (sensitivity of 76%), out of 23 patients with asthma (13%) and in out of 101 (3%) of patients with congestive heart failure [6] In a larger study of 157 patients, ... patients, the same investigators demonstrated presence of Hoover's sign in 71 patients (45 % of study population), and in 36%, 43 % and 76% respectively of patients with mild, moderate or severe COPD [3] ... molecular/structural basis of the Hoover's sign and explain how it could be utilized in the bedside and emergent management of severe airway disease Clinical presentation of Hoover's sign Case Report...
... journal of the American Association for the Study of Liver Diseases (AASLD), andof Current Hepatitis Reports, and a member of the Editorial Board of the Journal of Hepatology andof the Journal of ... genotypes and (B), and genotypes 4, and (C) Int J Med Sci 2006, HCV genotypes and Patients infected with HCV genotypes or have a 70%-80% likelihood of an SVR with a low dose of ribavirin and only 24 ... for a total of 48 weeks The virological response must be assessed by means of a sensitive HCV RNA assay (lower limit of detection of 50 IU/ml or less) at the end of therapy and 24 weeks later...
... B and C virus infection and risk of hepatocellular carcinoma in cirrhosis Cancer 19 94; 74: 244 2-8 31 Tsai JF, Jeng JE, Ho MS, Chang WY et al Effect of hepatitis C and B virus infection on risk of ... difficulties of managing hepatitis B infection Hence, further research and understanding in this sector may bring exciting new information and better understanding of the natural history of HBV and supplement ... activity, and with or without HBeAg seroreversion Clinical Spectrum of HBV Infection Primary Infection –Subclinical Infection and Acute hepatitis B Majority of HBV infection in children are subclinical...
... diagnostic method of TB was detection of Mycobacterium tuberculosis in the sputum on 1353 (56.3%) of patients, diagnosis by means ofclinicaland radiological findings on 346 ( 14. 4%) of patients, ... world population and the wider disparity of income, more and more people are falling into 2 94 (12.2) 46 (1.9) 10 (0 .4) (0.3) (0.29) (0.25) (0.2) (0.08) (0. 04) (0. 04) (0. 04) (0. 04) poverty, whichever ... Number of patients 191 1 14 42 28 20 15 11 7 (%) 7. 94 5.17 1.9 1.27 0.9 0.68 0 .49 0.36 0.31 0.31 0.27 0.22 0.13 0.09 0. 04 Table Clinical presentation of tuberculosis in the study group Clinical...
... Rehabilitation and Research Centre, University of Oulu, FIN-, Finland Axel Urhausen Institute of Sports and Preventitive Medicine, Department ofClinical Medicine, University of Saarland, D-, Saarbruecken, ... 135 80 60 (63a) 12 1 .4 1.3 48 >(22-) 27; exercise >1.0 45 >(22-) 27; exercise >1.0 43 (47 a) 43 (45 a) *Hypertrophic index (%) = septum + LV thickness (mm)/LVED diameter (mm) Functional adaptations ... of Anatomy, University of Kuopio, FIN-, Finland Jan Henriksson Department of Physiology and Pharmacology, Karolinska Institute, University of Stockholm, SE, Sweden Nils Hjeltness Department of...
... 79 :45 4 45 8 Dunsmuir RA and Gallacher G (2003) Microwave sterilization of femoral head allograft J Clin Microbiol 41 (10) :47 55 47 57 Fitzpatrick JA, Kwoa-Paul J, and Massey K (1978) Sterilization of ... Validation and Routine Control (20 04) 44 3 Appendix The IAEA Program on Radiation and Tissue Banking — Public Awareness Strategies for Tissue Banks (2002) 501 Index 545 FA March 19, 2007 14: 26 b478 Radiation ... bacteria by means of microwave heating J Clin Eng 3 :44 47 Hartman FW and Logrippo GA (1957) Betapropiolactone in sterilization of vaccines, tissue grafts, and plasma J Am Med Assoc 1 64( 3):258–260...
... 6.0 Fe(II)-HbIV Met-HbIV Fe(II)-HbI Met-HbI 40 40 40 40 40 < < < < < 3.00 1.20 1.80 3.00 5 .40 25.80 22.80 24. 60 24. 00 26 .40 (2 .45 3 (1.575 (0.929 (1.8 84 (1.207 ± ± ± ± ± 0.002) 0.010) 0.010) 0.010) ... explained by the reaction of oxoferrylHb with H2O2 with the production of met-Hb and oxygen instead of superoxide anion [8] Our data performed, at pH 5 .4, in the presence of H2O2 and guaiacol (as reductant) ... HbI and HbIV: iron(II)-HbI and met-HbI induce a 23.2 and 50.1% reduction of the peak intensity, respectively, when compared with the peak of the buffer Iron(II)-HbIV and metHbIV induce a 35.8 and...
... AZT, and reached 38% of the normal level in U937CD and 35% in MOLT4CD cells on day 15 In H2O2-treated cells, the level of ATP declined similarly On day 25, U937CD and MOLT4CD contained 45 and 48 % ... L (19 94) Mechanisms of endotoxin-induced haem oxygenase mRNA accumulation in mouse liver: synergism by glutathione depletion and protection by N-acetylcysteine Biochem J 3 04, 47 7 48 3 14 Anderson, ... activation of the NF-jB transcription factor and HIV-1 EMBO J 10, 2 247 –2258 10 Kurata S.-I (19 94) Potential of azidothimidine to activate the HIV-1 promoter J Biol Chem 269, 245 53– 245 56 11 Kurata,...